Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Hatakeyama
Institutions:
Hirosaki University,
Hirosaki University Hospital
Observed institutions:
Hirosaki University,
Hirosaki University Hospital
OpenAlex ID:
A5125953637
333 Slow gait speed and rapid renal function decline are risk factors for postoperative delirium after urological surgery
2016
·
S. Hatakeyama
, T. Sato
, et al.
·
European Urology Supplements
·
2
1963O JCOG1019: An open-label, non-inferiority, randomised phase III study comparing the effectiveness of watchful waiting (WW) and intravesical Bacillus Calmette-Guérin (BCG) in patients (Pts) with high-grade pT1 (HGT1) bladder cancer with pT0 on the second transurethral resection (TUR) specimen
2024
·
H. Kitamura
, J. Mizusawa
, et al.
·
Annals of Oncology
·
1
PDF
Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
2022
·
S. Hatakeyama
, T. Yoneyama
, et al.
·
European Urology
·
1
PSY1-3 Addressing unmet needs in UTUC: Asian evidence and the future of perioperative treatment development
2026
·
S. Hatakeyama
·
Annals of Oncology
P0185 Beyond testosterone: The role of dehydroepiandrosterone sulfate and estradiol in erectile dysfunction in men without hypoandrogenism
2026
·
N. Fujita
, T. Okamoto
, et al.
·
European Urology
A0307 A study on the utility of the Glasgow Prognostic Score (GPS) in treatment selection for metastatic renal cell carcinoma
2026
·
F. Yoneyama
, H. Kodama
, et al.
·
European Urology
A0006 External validation of a prognostic risk model for overall survival after Radium-223 treatment in metastatic castration-resistant prostate cancer
2026
·
N. Fujita
, T. Kato
, et al.
·
European Urology
P0038 Clinical significance of the De Ritis ratio in patients with metastatic hormonesensitive prostate cancer treated with upfront therapy
2026
·
T. Ichiyama
, N. Fujita
, et al.
·
European Urology
P0465 Are real-world patients with mRCC receiving sequential therapies as in trials? A comparative study
2026
·
H. Sato
, Y. Sekine
, et al.
·
European Urology
A0856 Real-world efficacy of avelumab maintenance therapy in advanced urothelial carcinoma: Survival impact of early transition after 2–3 cycles of chemotherapy
2026
·
N. Ishii
, Y. Sekine
, et al.
·
European Urology
P0027 Lack of association between oxidative stress and erectile dysfunction in diverse male populations
2026
·
N. Fujita
, M. Momota
, et al.
·
European Urology
A0576 Impact of atherosclerosis on acute kidney injury after radical cystectomy or nephroureterectomy
2026
·
N. Ishii
, N. Fujita
, et al.
·
European Urology
A0521 Risk stratification in high-volume mHSPC: Challenges in applying prognostic models to the triplet era
2026
·
K Miyajima
, T. Yanagisawa
, et al.
·
European Urology
P0642 Prognostic impact of neoadjuvant chemotherapy for muscle-invasive bladder cancer in patients with low geriatric nutritional risk index: A retrospective cohort study
2026
·
S. Omizo
, N. Fujita
, et al.
·
European Urology
P0816 The longitudinal association between lower urinary tract symptoms severity and sarcopenia progression in community-dwelling men: A 4-year study
2026
·
T. Okamoto
, H. Sato
, et al.
·
European Urology
P642 – Trends in the use of perioperative therapy and effects of adjuvant immunotherapy on prognosis for muscle-invasive urothelial carcinoma: A multicenter study
2025
·
S. Hatakeyama
, N. Fujita
, et al.
·
European Urology
A0658 – Efficacy and safety of enfortumab vedotin in urothelial carcinoma: A real-world multicenter study
2025
·
K. Ozaki
, H. Yamamoto
, et al.
·
European Urology
A0743 – Association of muscle quantity and quality with acute kidney injury development in patients who undergo radical cystectomy
2025
·
N. Fujita
, S. Hosogoe
, et al.
·
European Urology
Comparison of qSOFA score and SIRS criteria for assessing the risk for severe acute kidney injury development and mortality in febrile urinary tract infection
2024
·
N. Fujita
, M. Momota
, et al.
·
European Urology
Plasma hyaluronan levels predict major adverse cardiovascular events in urological sepsis
2024
·
M. Momota
, N. Fujita
, et al.
·
European Urology
Association between elevated plasma thrombin-antithrombin complex levels and severe acute kidney injury development in urological sepsis
2024
·
N. Fujita
, M. Momota
, et al.
·
European Urology
Impact of maximal transurethral resection prior to neoadjuvant chemotherapy on oncological outcomes in patients who undergo radical cystectomy: A multicenter retrospective study
2024
·
N. Fujita
, T. Tanaka
, et al.
·
European Urology
Impact of chronic kidney disease on prognosis in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant induction bacillus Calmette-Guérin therapy
2024
·
N. Fujita
, M. Momota
, et al.
·
European Urology
Trans-ethnic comprehensive genomic cluster stratification of upper tract urothelial carcinoma
2023
·
T-C. Wei
, Y-F. Lin
, et al.
·
European Urology
An optimized surveillance protocol based on the European Association of Urology substratification improves surveillance costs after transurethral resection of bladder tumor in patients with high-risk non-muscle-invasive bladder cancer
2023
·
N. Fujita
, S. Hatakeyama
, et al.
·
European Urology
Show more works
View as search
Works count:
52
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type